JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Nakache, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Nakache, R.
Journal of Nuclear Medicine Vol. 43 No. 5 584-588
© 2002 by Society of Nuclear Medicine


Clinical Investigations

Kidney Allografts and Remaining Contralateral Donor Kidneys Before and After Transplantation: Assessment by Quantitative 99mTc-DMSA SPECT

Einat Even-Sapir, MD, DSc1, Mordechai Gutman, MD2, Hedva Lerman, MD1, Eli Kaplan, MD2, Anat Ravid, MD2, Genady Livshitz, MD1 and Richard Nakache, MD2

1 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel
2 Organ Transplantation Unit, Department of Surgery "B," Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel

We used 99mTc-dimercaptosuccinic acid (DMSA) quantitative SPECT (QDMSA) to assess the function of kidneys before harvesting and after transplantation as well as the function of remaining donor kidneys. Methods: Nineteen kidney donors underwent a baseline QDMSA study before nephrectomy. The allografts of these kidneys were studied in recipients at 1 wk, 1–2 mo, and 6–15 mo after transplantation. The kidneys remaining in 16 donors were studied at 1–2 mo and 6–15 mo after harvesting. The parameters obtained in each SPECT study included functional volume, concentration of 99mTc-DMSA per cubic centimeter of renal tissue, and total kidney uptake. Clinical evaluation and determination of serum creatinine levels took place at the same time as SPECT. Results: On the basis of the clinical evaluation, 14 grafts had normal function and 5 were impaired. The mean ± SD of kidney uptake values expressed as percentage of baseline values were 131% ± 30% in normal grafts versus 57% ± 5% in impaired grafts at 1 wk (P < 0.01), 173% ± 57% versus 65% ± 10% at 1–2 mo (P < 0.001), and 190% ± 50% versus 69% ± 14% at 6–15 mo after transplantation (P < 0.01). Uptake values in the donors’ remaining kidneys were 159% ± 27% of baseline values at 1–2 mo and 164% ± 30% at 6–15 mo after nephrectomy. Allografts and remaining kidneys showed a similar increase in total kidney uptake as a result of an increase in both functional volume and concentration. Conclusion: QDMSA may be a noninvasive assessment tool in kidney transplantation from living donors.

Key Words: transplantation • SPECT • 99mTc-dimercaptosuccinic acid







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.